Belite Bio, Inc

NASDAQ:BLTE

Biotechnology

Healthcare
$151.02 +0.31%

+$0.46 today

Market cap
$6.08B
Beta
-1.24
P/E (TTM)
-65.9
EPS (TTM)
-$2.26
52W Low $56.10High $200.00

Volume 0.14M

Average 0.17M

Balance Sheet

Inspect the capital base behind the business.

Assets

$780.56M

FY 2025 · Annual

+413.1% YoY

Liabilities

$10.07M

FY 2025 · Annual

+59.6% YoY

Equity

$770.49M

FY 2025 · Annual

+428.4% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents17.34M42.09M88.16M31.68M352.93M
Short-term Investments000113.47M139.49M
Net Receivables23K19K867K594K718K
Inventory00000
Other Current Assets00005K
Total Current Assets17.43M42.81M89.94M147.07M494.27M
Property, Plant & Equipment (Net)94K1.35M1.3M965K777K
Goodwill00000
Intangible Assets031K3.3M3.99M4.92M
Long-term Investments0000280.17M
Tax Assets00000
Other Non-current Assets823K88K104K103K425K
Total Non-current Assets917K1.47M4.7M5.06M286.28M
Total Assets18.35M44.27M94.64M152.13M780.56M
Account Payables00000
Short-term Debt00000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities24K456K876K992K2.21M
Total Current Liabilities1.64M2.1M3.63M6.05M9.88M
Long-term Debt31.81M0000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities00000
Total Non-current Liabilities31.81M668K578K261K188K
Total Liabilities33.44M2.77M4.21M6.31M10.07M
Common Stock1K3K3K3K4K
Retained Earnings(27.22M)(39.87M)(71.5M)(107.65M)(185.26M)
Accumulated OCI(196K)(392K)(374K)(660K)(536K)
Other Stockholders Equity00000
Minority Interest00000
Total Equity(15.09M)41.5M90.43M145.82M770.49M
Total Debt31.81M866K886K537K429K
Net Debt14.46M(41.22M)(87.27M)(31.14M)(352.5M)

Balance Sheet

Assets, liabilities & equity

Other Current$501.6M
Total Current Assets$501.6M
Other Non-current$290.0M
Total Non-current Assets$290.0M
Total Assets$791.6M

Analysis

Selected assets total $791.6M for Latest. The largest visible component is Other Current at $501.6M, about 63.4% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
6-K6-K filingOct 19, 2026

How much cash does BLTE have?

Belite Bio, Inc (BLTE) reported $352.93M in cash and equivalents in fiscal 2025.

How much debt does BLTE carry?

Belite Bio, Inc (BLTE) reported $429,000.00 of total debt, with net debt of -$352.50M.